Little Green Pharma Ltd (LGP.AX)
AUD 0.13
(-3.85%)
AUD 0.13
(-3.85%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.31 Million AUD | 40.38% |
| 2022 | 3.78 Million AUD | 211.2% |
| 2021 | 1.21 Million AUD | -15.87% |
| 2020 | 1.44 Million AUD | 8.6% |
| 2019 | 1.33 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.04 Million AUD | 0.0% |
| 2024 Q1 | 3.04 Million AUD | -42.36% |
| 2023 Q3 | 5.28 Million AUD | 37.06% |
| 2023 FY | 5.31 Million AUD | 40.38% |
| 2023 Q4 | 5.28 Million AUD | 0.0% |
| 2023 Q2 | 3.85 Million AUD | 0.0% |
| 2023 Q1 | 3.85 Million AUD | 0.0% |
| 2022 Q3 | - AUD | 0.0% |
| 2022 Q1 | 1.21 Million AUD | 0.0% |
| 2022 Q2 | - AUD | -100.0% |
| 2022 FY | 3.78 Million AUD | 211.2% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | 1.21 Million AUD | -15.87% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 FY | 1.44 Million AUD | 8.6% |
| 2020 Q3 | - AUD | 0.0% |
| 2020 Q2 | - AUD | -100.0% |
| 2020 Q1 | 1.33 Million AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | 1.33 Million AUD | 0.0% |
| 2019 Q4 | 1.33 Million AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | - AUD | -Infinity% |
| Cann Group Limited | 421 Thousand AUD | -1161.652% |
| ECS Botanics Holdings Ltd | - AUD | -Infinity% |
| Ecofibre Limited | 9.5 Million AUD | 44.089% |
| Elixinol Wellness Limited | 178 Thousand AUD | -2884.019% |
| Hygrovest Limited | - AUD | -Infinity% |
| IDT Australia Limited | - AUD | -Infinity% |
| Invion Limited | - AUD | -Infinity% |
| Live Verdure Ltd | - AUD | -Infinity% |
| Medical Developments International Limited | 1.91 Million AUD | -177.366% |
| Vitura Health Limited | 4.11 Million AUD | -28.955% |
| Vita Life Sciences Limited | 176 Thousand AUD | -2917.928% |